Synthesis and Structure activity relationships of EGCG Analogues, A Recently Identified Hsp90 Inhibitor
View/ Open
Issue Date
2013-08-16Author
Khandelwal, Anuj
Hall, Jessica Ann
Blagg, Brian S. J.
Publisher
American Chemical Society
Type
Article
Article Version
Scholarly/refereed, author accepted manuscript
Rights
This document is the Accepted Manuscript version of a Published Work that appeared in final form in the Journal of Organic Chemistry, copyright © American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see http://dx.doi.org/10.1021/jo401027r.
Metadata
Show full item recordAbstract
Epigallocatechin-3-gallate (EGCG), the principal polyphenol isolated from green tea, was recently shown to inhibit Hsp90, however structure-activity relationships for this natural product have not yet been produced. Herein, we report the synthesis and biological evaluation of EGCG analogues to establish structure-activity relationships between EGCG and Hsp90. All four rings as well as the linker connecting the C- and the D-rings were systematically investigated, which led to the discovery of compounds that inhibit Hs90 and display improvement in efficacy over EGCG. Anti-proliferative activity of all the analogues was determined against MCF-7 and SKBr3 cell lines and Hsp90 inhibitory activity of four most potent analogues was further evaluated by western blot analyses and degradation of Hsp90-dependent client proteins. Prenyl substituted aryl ester of 3,5-dihydroxychroman-3-ol ring system was identified as novel scaffold that exhibit Hsp90 inhibitory activity.
Collections
Citation
Khandelwal, A., Hall, J., & Blagg, B. S. J. (2013). Synthesis and Structure activity relationships of EGCG Analogues, A Recently Identified Hsp90 Inhibitor. The Journal of Organic Chemistry, 78(16), 7859–7884. http://doi.org/10.1021/jo401027r
Items in KU ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
We want to hear from you! Please share your stories about how Open Access to this item benefits YOU.